PFN1P8: A Promising Drug Target / Biomarker (G100873744)

Target Name: PFN1P8

NCBI ID: G100873744

PFN1P8

Other Name(s): Profilin 1 pseudogene 8 | profilin 1 pseudogene 8

PFN1P8: A Promising Drug Target / Biomarker

PFN1P8 is a protein that is expressed in various tissues of the body, including the brain, heart, and blood vessels. It is a member of the PFN1 family of proteins, which are known for their role in cell-cell adhesion. PFN1P8 has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

PFN1P8 functions as a cell adhesion molecule that helps maintain the integrity of tissues. It plays a critical role in the formation of tight junctions, which are specialized structures that mediate cell-cell communication and help maintain tissue barrier integrity. PFN1P8 is also involved in the regulation of cell proliferation and differentiation, as well as in the development and maintenance of tissues.

Drug targeting PFN1P8:

PFN1P8 has been identified as a potential drug target for various diseases due to its unique structure and function. One of the main advantages of PFN1P8 is its ability to interact with a variety of signaling molecules, including TGF-β, Wnt, andNotch. These molecules are involved in various cellular processes that are important for the development and maintenance of tissues, including cell growth, differentiation, and survival.

PFN1P8 has also been shown to play a role in the regulation of the blood-brain barrier (BBB), which is a specialized barrier that separates the brain from the bloodstream. The BBB helps to ensure that only certain substances are able to enter the brain and is involved in the development of neurodegenerative diseases. By targeting PFN1P8, researchers may be able to develop new treatments for conditions such as Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.

PFN1P8 has also been shown to be involved in the regulation of cell signaling pathways that are important for cancer development. In fact, several studies have suggested that PFN1P8 may be a potential target for cancer therapy. By inhibiting the activity of PFN1P8, researchers may be able to inhibit the growth and survival of cancer cells.

Biomarker identification:

PFN1P8 has also been identified as a potential biomarker for various diseases. For example, some studies have suggested that PFN1P8 may be a potential biomarker for cancer. By measuring the expression of PFN1P8 in cancer cells and comparing it to the expression in normal cells, researchers may be able to identify new biomarkers for cancer diagnosis and treatment.

Another study has suggested that PFN1P8 may be a potential biomarker for neurodegenerative diseases. By measuring the expression of PFN1P8 in brain tissue from individuals with neurodegenerative diseases, researchers may be able to identify new biomarkers for the diagnosis and treatment of these conditions.

Conclusion:

PFN1P8 is a protein that has been identified as a potential drug target or biomarker for various diseases. Its unique structure and function make it an attractive target for research into the development and treatment of a wide range of conditions. Further studies are needed to fully understand the role of PFN1P8 in various biological processes and to develop new treatments based on its unique properties.

Protein Name: Profilin 1 Pseudogene 8

The "PFN1P8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PFN1P8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets